Clinical trials
Phase 3 Overweight trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 8 |
| 2025 | 9 |
| 2026 | 26 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 24 |
| Completed | 17 |
| Active, not recruiting | 9 |
| Not yet recruiting | 5 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 18 |
| Novo Nordisk A/S | 7 |
| AstraZeneca | 4 |
| Hoffmann-La Roche | 3 |
| Gan & Lee Pharmaceuticals. | 2 |
| Innovent Biologics (Suzhou) Co. Ltd. | 2 |
| Pfizer | 2 |
| Amgen | 1 |
| Beijing QL Biopharmaceutical Co.,Ltd | 1 |
| Boehringer Ingelheim | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 56 |
| Obesity | 54 |
| Diabetes Mellitus, Type 2 | 10 |
| Weight Loss | 4 |
| Sleep Apnea, Obstructive | 3 |
| Body Weight | 2 |
| Nutrition Disorders | 2 |
| Prediabetic State | 2 |
| Atherosclerosis | 1 |
| Hypertension | 1 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.